According to the report of the Medical Working Group on the Safety of Coronavirus Vaccines (VaST), mRNA-based vaccination Vaccination in adolescents and young adults in particular increases the risk of developing myocarditis or pericarditis after the second vaccination, and in men in general.
In another report, the CDC reported that heart patients usually recover after vaccination, their symptoms disappear and they are fine.
The Advisory Committee on Immunization Practices (ACIP) will meet on Wednesday to examine the potential link between heart disease and mRNA-based vaccines. VaST is a clinical working group of ACIP.
Israel’s Ministry of Health reported in the first half of June that it had found a possible link between heart infections and Pfizer’s vaccination, yet the fear of a more contagious delta in Israel encouraged children aged 12 to 15 to vaccinate themselves.
The CDC has been investigating cases of carditis, especially among young adults, for months. The agency confirmed in June that it was still analyzing the risks posed by symptoms and could not confirm a causal link between vaccinations and heart disease. However, the CDC confirmed that a higher than expected number of young adults developed heart disease after the second mRNA-based vaccination, and that more than half of these cases occurred in men aged 12 to 24 years.
According to the ACIP meeting agenda, the committee will compare and discuss the benefits of mRNA-based vaccines and the potential risks of heart disease for adolescents and young adults.
a Pfizer The company, which is officially approved to vaccinate Americans over the age of 12, said it has not seen a higher-than-expected rate of heart inflammation after using the Pfizer/BioNTech vaccine.
a modern According to previous information from the company, no causal relationship was found between the incidence of heart disease and the use of the Moderna vaccine.
More than 138 million Americans have been vaccinated twice with one of the two RNA-based vaccines, according to CDC data Monday.
Cover photo source: MTI / Péter Komka
